Lisanti Capital Growth, LLC Intellia Therapeutics, Inc. Transaction History

Lisanti Capital Growth, LLC

  • $384 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022
SELL
$58.27 - $118.99 $1.21 Million - $2.47 Million
-20,730 Closed
0 $0
Q4 2021

Feb 04, 2022
SELL
$100.76 - $138.36 $35,769 - $49,117
-355 Reduced 1.68%
20,730 $2.45 Million
Q3 2021

Nov 03, 2021
SELL
$132.37 - $176.78 $1.64 Million - $2.19 Million
-12,385 Reduced 37.0%
21,085 $2.83 Million
Q2 2021

Aug 16, 2021
BUY
$60.88 - $161.91 $2.04 Million - $5.42 Million
33,470 New
33,470 $5.42 Million

Others Institutions Holding NTLA

# of Institutions
320
Shares Held
88.6M
Call Options Held
673K
Put Options Held
865K
View Full List

About Intellia Therapeutics, Inc.

NTLA Quotes by TradingView
  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $1.08B
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track Lisanti Capital Growth, LLC Portfolio

Follow Lisanti Capital Growth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lisanti Capital Growth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lisanti Capital Growth, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email